Commenting today on the Centers for Medicare & Medicaid Services’ proposed rule for the inpatient rehabilitation facility prospective payment system for fiscal year 2020, AHA said it generally supports the reforms to update the payment system, but expressed concern with the substantial redistribution of cases under the payment model proposed for FY 2020. The comment letter raises concerns regarding the FY 2020 case-mix system reforms finalized in last year’s rulemaking, as well as proposed changes to quality outcomes reporting and patient assessments. “[W]e remain concerned that these new policies are, in part, based on unreliable data and that the proposed rule lacks adequate detail and transparency,” AHA wrote. “We also are concerned that the proposed rule lacks the patient-level and cost data needed to replicate the model for the purpose of evaluating its impact to consider whether alternatives would be warranted. These issues deserve further discussion and transparency in the final rule to allow the field to best prepare for the changes and serve their patients.”

Related News Articles

Headline
The Centers for Medicare & Medicaid Services July 2 announced that Maryland, Vermont and Connecticut will be the first participants in the States Advancing…
Headline
The AHA, 340B Health, Maryland Hospital Association and Mid-Atlantic Association of Community Health Centers July 9 filed an amicus brief in a federal district…
Headline
The House Appropriations Committee July 10 voted 31-25 to approve legislation that would provide $185.8 billion in funding for the departments of Labor, Health…
Headline
The Centers for Medicare & Medicaid Services July 10 issued a proposed rule that would increase Medicare hospital outpatient prospective payment system…
Headline
The Centers for Medicare & Medicaid Services July 8 announced over 400 participants in a new model focused on improving dementia care. The Guiding an…
Headline
In a letter submitted July 2 to the Centers for Medicare & Medicaid Services on guidance for the Medicare Drug Price Negotiation Program, the AHA expressed…